Biosimilars are the medicines similar to biological drugs (obtained with the use of living cells) while "generics" refer to small molecule drugs (obtained by chemical synthesis).
Generics are considered identical and interchangeable while biosimilars are "only similar" and can not be automatically perceived as interchangeable.
The Needlestick Safety and Prevention Act (the Act) (Pub. L. 106-430) was signed into law on November 6, 2000. Because occupational exposure to bloodborne pathogens from accidental sharps injuries in healthcare and other occupational settings continues to be a serious problem, Congress felt that a modification to OSHA's Bloodborne Pathogens Standard was appropriate (29 CFR 1910.1030) to set forth in greater detail (and make more specific) OSHA's requirement for employers to identify, evaluate, and implement safer medical devices. The Act also mandated additional requirements for maintaining a sharps injury log and for the involvement of non-managerial healthcare workers in evaluating and choosing devices.
Answer:
I: Initial Inflammatory phase
M: Mobility Restoration phase
P: Proprioception phase
R:Resistance Phase
E:Endurance training phase
SS:Sports specific Function phase
Explanation:
Like an example?
if an example it can be
<span>Alzheimer's disease</span>